Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A
Authors:
- 7 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 917, 174749
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81960767)
- Natural Science Foundation of Guangxi Province (2018GXNSFAA050107)
This publication has 37 references indexed in Scilit:
- Light-sheet microscopy for slide-free non-destructive pathology of large clinical specimensNature Biomedical Engineering, 2017
- AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study2017
- Suppressive effect of Spirulina fusiformis on diclofenac-induced hepato-renal injury and gastrointestinal ulcer in Wistar albino rats: A biochemical and histological approachBiomedicine & Pharmacotherapy, 2017
- Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many YearsMolecules, 2017
- Hepatoprotective Effect of Polyphenol‐Enriched Fraction from Folium Microcos on Oxidative Stress and Apoptosis in Acetaminophen‐Induced Liver Injury in MiceOxidative Medicine and Cellular Longevity, 2017
- A review on the pharmacological effects of vitexin and isovitexinFitoterapia, 2016
- NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKRCell Reports, 2016
- Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensusProceedings of the National Academy of Sciences, 2014
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift AssayScience, 2013
- Flavonoid C- and O-glycosides from the Mongolian medicinal plant Dianthus versicolor Fisch.Carbohydrate Research, 2011